# A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)

> **NCT05515367** · PHASE4 · RECRUITING · sponsor: **Zydus Lifesciences Limited** · enrollment: 1004 (estimated)

## Conditions studied

- Chronic Kidney Diseases
- Anemia of Chronic Kidney Disease

## Interventions

- **DRUG:** Desidustat

## Key facts

- **NCT ID:** NCT05515367
- **Lead sponsor:** Zydus Lifesciences Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-20
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 1004 (ESTIMATED)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05515367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05515367, "A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05515367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*